Saunderson, CED;
Plein, S;
Manisty, CH;
(2021)
Role of cardiovascular magnetic resonance imaging in cardio-oncology.
European Heart Journal - Cardiovascular Imaging
, 22
(4)
pp. 383-396.
10.1093/ehjci/jeaa345.
Preview |
Text
Manisty_Role of cardiovascular magnetic resonance imaging in cardio-oncology_AAM.pdf - Accepted Version Download (1MB) | Preview |
Abstract
Advances in cancer therapy have led to significantly longer cancer-free survival times over the last 40 years. Improved survivorship coupled with increasing recognition of an expanding range of adverse cardiovascular effects of many established and novel cancer therapies has highlighted the impact of cardiovascular disease in this population. This has led to the emergence of dedicated cardio-oncology services that can provide pre-treatment risk stratification, surveillance, diagnosis, and monitoring of cardiotoxicity during cancer therapies, and late effects screening following completion of treatment. Cardiovascular imaging and the development of imaging biomarkers that can accurately and reliably detect pre-clinical disease and enhance our understanding of the underlying pathophysiology of cancer treatment-related cardiotoxicity are becoming increasingly important. Multi-parametric cardiovascular magnetic resonance (CMR) is able to assess cardiac structure, function, and provide myocardial tissue characterization, and hence can be used to address a variety of important clinical questions in the emerging field of cardio-oncology. In this review, we discuss the current and potential future applications of CMR in the investigation and management of cancer patients.
| Type: | Article |
|---|---|
| Title: | Role of cardiovascular magnetic resonance imaging in cardio-oncology |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1093/ehjci/jeaa345 |
| Publisher version: | https://doi.org/10.1093/ehjci/jeaa345 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions. |
| Keywords: | cancer, cardio-oncology, cardiotoxicity, cardiovascular magnetic resonance, left ventricular dysfunction |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Clinical Science |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10126810 |
Archive Staff Only
 |
View Item |
